Vaccines & Biodefense

In the U.S., the recommended immunization series prevents approximately 33,000 deaths each year. Advancements in biotechnology have made it possible to produce vaccines that cannot transmit a virus or bacterium. This method has helped create more than 20 new vaccines against infectious agents, improved existing vaccines, and increased the amount of vaccine that can be produced.

Coronavirus
Biotech Response to COVID-19

As the threat of the novel coronavirus continues to grow globally, innovative biopharmaceutical companies are ramping up efforts to study the virus and develop vaccines and cures to protect individuals from contracting the virus.

Blog Posts
Covid Vaccine
June 3, 2021
As the world continues to contend with the challenges of  the COVID-19 pandemic, one of the most important ways that the virus is being combatted is through COVAX, the global mechanism for equitable access to COVID…
Covid Vaccine
May 24, 2021
What will it take to end the pandemic? A true return to normalcy includes international travel and the movement of people globally. But how do we do this safely? How do we get vaccines to poorer areas of the world? As…
Good Trouble for Good Medicine
May 11, 2021
COVID-19 has brought to light many failures in our healthcare system – including the long-running issue of the lack of diversity in clinical trials. To understand how therapeutics or vaccines may affect a large…
Press Releases
May 18, 2021
"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE” program, we’ve made clear the urgent need to…
April 20, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), yesterday sent a letter to U.S. Trade Representative (USTR) Ambassador Katherine Tai sharing BIO perspectives regarding the proposed WTO “TRIPS waiver” for COVID related products. The letter, written…
March 18, 2021
The Biotechnology Innovation Organization (BIO) welcomes the confirmations this week of Katherine Tai to the position of U.S. Trade Representative (USTR) and Xavier Becerra to lead the Department of Health and Human Services (HHS).  The United States leads the world in biotechnology…
Letters, Comments & Testimony
June 9, 2021
BIO would like to formally support the nomination of Dawn O’Connell to serve as the Department of Health and Human Services (HHS) Assistant Secretary for Preparedness and Response (ASPR). The Biotechnology Innovation Organization (“BIO”) is the world’s largest trade association representing…
April 6, 2021
On Tuesday, April 6th, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s January 2021 draft industry guidance on “Human Gene Therapy for Neurodegenerative Diseases.” In its comments, BIO stated that while the guidance covers many critical development issues for gene therapies,…
March 26, 2021
On Friday, March 26th, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s public meeting announcement titled, “Best Practices for Development and Application of Disease Progression Models.” BIO appreciates that FDA is seeking input from stakeholders on three key areas,…
Patient-Take-Action
Become an Advocate for Biotechnology

Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.